Overview
- Colorado’s bipartisan House Bill 26-1325, which would fund a $150,000 ibogaine research pilot, is stuck in the Appropriations Committee because of a $1.5 billion state budget gap.
- Supporters include three veteran lawmakers, Gov. Jared Polis, and the Disabled American Veterans, who say the pilot would study ibogaine for PTSD, addiction, and other mental health needs.
- President Donald Trump’s recent executive order directs the FDA and DEA to review ibogaine’s status and to create a pathway for eligible patients to access psychedelic compounds.
- Ibogaine remains illegal in the U.S. as a Schedule I substance, so some Americans travel to clinics in Mexico, where one operator reported increased inquiries and charges between $5,000 and $25,000 per treatment.
- Mississippi moved ahead with an ibogaine-focused law signed by Gov. Tate Reeves in recent weeks, while safety concerns persist, including a 2021 Colorado death that led to a four-year sentence for the distributor.